| | | | | | Préparation | Taille des prés. | PEF | PP | QP | CQ | Composition | Titulaire de l'aut. | Cat. | | | | |
|---|
| Qu'est-ce que c'est le code ATC? | Index ATC |
|
| | | IPro | | | Ampres 30 mg/ml | Flacon perforable à 20 ml | | | N.O. | | Solution injectable: Chloroprocaini Hydrochloridum 30 mg/ml | Sintetica SA | B | FB | | G |  |
| | | IPro | | | Ampres 20 mg/ml | Flacon perforable à 20 ml | | | N.O. | | Solution injectable: 2 Principes actifs | Sintetica SA | B | FB | | G | |
| | | IPro | | | Ampres intrathecal 10
mg/ml | 10 x 5 ml | | | N.O. | | Solution injectable: Chloroprocaini Hydrochloridum 10 mg/ml | Sintetica SA | B | FB | | G | |
| | | IPro | | | Ivracain 5mg/ml | 20 ml | | | N.O. | | Solution injectable: Chloroprocaini Hydrochloridum 5 mg/ml | Sintetica SA | B | FB | | G | |
| | | IPro | | | Ivracain 5mg/ml | 5 1 ampoule(s) à 20 ml | | | N.O. | | Solution injectable: Chloroprocaini Hydrochloridum 5 mg/ml | Sintetica SA | B | FB | | G | |
| | | IPro | | | Ampres 10 mg/ml | 10 1 ampoule(s) à 5 ml | | | N.O. | | Solution injectable: Chloroprocaini Hydrochloridum 10 mg/ml | Sintetica SA | B | FB | | G | |
| | | IPro | | | Ampres 30 mg/ml | 5 1 ampoule(s) à 20 ml | | | N.O. | | Solution injectable: Chloroprocaini Hydrochloridum 30 mg/ml | Sintetica SA | B | FB | | G | |
| | | IPro | | | Ampres 20 mg/ml | 5 1 ampoule(s) à 20 ml | | | N.O. | | Solution injectable: 2 Principes actifs | Sintetica SA | B | FB | | G | |
| | | IPro | | | Ampres intrathecal 10
mg/ml | 10 x 5 ml | | | N.O. | | Solution injectable: Chloroprocaini Hydrochloridum 10 mg/ml | Sintetica SA | B | FB | | G | |
|
| | | IPro | | | Bupivacain 5 mg/ml
hyperbar Sintetica | 10 x 4 ml | | | N.O. | | Solution injectable: Bupivacaini Hydrochloridum Anhydricum 5 mg/ml | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain 5 mg/ml
hyperbar Sintetica | 10 x 4 ml | | | N.O. | | Solution injectable: Bupivacaini Hydrochloridum Anhydricum 5 mg/ml | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica 2,5
mg/ml | 10 1 ampoule(s) à 5 ml | | 34.80 | N.O. | | Solution injectable: Bupivacaini Hydrochloridum Anhydricum 2.5 mg | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica 2,5
mg/ml | 10 x 5 ml | | | N.O. | | Solution injectable: Bupivacaini Hydrochloridum Anhydricum 2.5 mg | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica 2,5
mg/ml | 5 1 ampoule(s) à 20 ml | | | N.O. | | Solution injectable: Bupivacaini Hydrochloridum Anhydricum 2.5 mg | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica 5
mg/ml vial | 20 ml | | | N.O. | | Solution injectable: Bupivacaini Hydrochloridum Anhydricum 5 mg | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica 5
mg/ml ampoule | 10 x 5 ml | | | N.O. | | Solution injectable: Bupivacaini Hydrochloridum Anhydricum 5 mg | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica 5
mg/ml ampoule | 5 x 20 ml | | | N.O. | | Solution injectable: Bupivacaini Hydrochloridum Anhydricum 5 mg | Sintetica SA | B | FB | | G | |
| | | IPro | | | Carbostesin 0,25 % | 5 1 ampoule(s) à 5 ml | | | N.O. | | Solution injectable: Bupivacaini Hydrochloridum Anhydricum 2.5 mg/ml | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | IPro | | | Carbostesin 0,25 % | 5 1 ampoule(s) à 20 ml | | | N.O. | | Solution injectable: Bupivacaini Hydrochloridum Anhydricum 2.5 mg/ml | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | IPro | | | Carbostesin 5 mg/ml
hyperbar | 5 1 ampoule(s) à 4 ml | | 63.40 | N.O. | | Solution injectable: Bupivacaini Hydrochloridum Anhydricum 5 mg/ml | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | IPro | | | Carbostesin 0,5 % | 5 1 ampoule(s) à 5 ml | | | N.O. | | Solution injectable: Bupivacaini Hydrochloridum Anhydricum 5 mg/ml | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | IPro | | | Carbostesin 0,5 % | 5 1 ampoule(s) à 20 ml | | | N.O. | | Solution injectable: Bupivacaini Hydrochloridum Anhydricum 5 mg/ml | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica 40
mg/ml | 10 x 5 ml | | | N.O. | | concentrato per soluzione iniettabile: Bupivacaini Hydrochloridum Anhydricum 40 mg | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica 2,5
mg/ml | 20 ml | | | N.O. | | soluzione iniettabile o per infusione: Bupivacaini Hydrochloridum Anhydricum 2.5 mg | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica 2,5
mg/ml | 5 x 250 ml | | | N.O. | | soluzione iniettabile o per infusione: Bupivacaini Hydrochloridum Anhydricum 2.5 mg | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica 1,25
mg/ml | 50 ml | | | N.O. | | soluzione per infusione: Bupivacaini Hydrochloridum Anhydricum 1.25 mg | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica 1,25
mg/ml | 10 x 100 ml | | | N.O. | | soluzione per infusione: Bupivacaini Hydrochloridum Anhydricum 1.25 mg | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica 1,25
mg/ml | 5 x 250 ml | | | N.O. | | soluzione per infusione: Bupivacaini Hydrochloridum Anhydricum 1.25 mg | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica 5
mg/ml vial | 5 ml | | | N.O. | | Solution injectable: Bupivacaini Hydrochloridum Anhydricum 5 mg | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica 5
mg/ml ampoule | 10 x 5 ml | | | N.O. | | Solution injectable: Bupivacaini Hydrochloridum Anhydricum 5 mg | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica 40
mg/ml | 10 1 ampoule(s) à 5 ml | | | N.O. | | concentrato per soluzione iniettabile: Bupivacaini Hydrochloridum Anhydricum 40 mg | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica 2,5
mg/ml | 5 ml | | | N.O. | | soluzione iniettabile o per infusione: Bupivacaini Hydrochloridum Anhydricum 2.5 mg | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica 2,5
mg/ml | 250 ml | | | N.O. | | soluzione iniettabile o per infusione: Bupivacaini Hydrochloridum Anhydricum 2.5 mg | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica 2,5
mg/ml | 500 ml | | | N.O. | | soluzione iniettabile o per infusione: Bupivacaini Hydrochloridum Anhydricum 2.5 mg | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica 2,5
mg/ml | 10 x 500 ml | | | N.O. | | soluzione iniettabile o per infusione: Bupivacaini Hydrochloridum Anhydricum 2.5 mg | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica
0.625 mg/ml | 250 ml | | | N.O. | | soluzione per infusione: Bupivacaini Hydrochloridum Anhydricum | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica
0.625 mg/ml | 500 ml | | | N.O. | | soluzione per infusione: Bupivacaini Hydrochloridum Anhydricum | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica
0.625 mg/ml | 5 x 250 ml | | | N.O. | | soluzione per infusione: Bupivacaini Hydrochloridum Anhydricum | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica
0.625 mg/ml | 10 x 500 ml | | | N.O. | | soluzione per infusione: Bupivacaini Hydrochloridum Anhydricum | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica 1
mg/ml | 100 ml | | | N.O. | | soluzione per infusione: Bupivacaini Hydrochloridum Anhydricum 1 mg | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica 1
mg/ml | 10 x 100 ml | | | N.O. | | soluzione per infusione: Bupivacaini Hydrochloridum Anhydricum 1 mg | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica 1,25
mg/ml | 100 ml | | | N.O. | | soluzione per infusione: Bupivacaini Hydrochloridum Anhydricum 1.25 mg | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica 1,25
mg/ml | 250 ml | | | N.O. | | soluzione per infusione: Bupivacaini Hydrochloridum Anhydricum 1.25 mg | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica 1,25
mg/ml | 1000 ml | | | N.O. | | soluzione per infusione: Bupivacaini Hydrochloridum Anhydricum 1.25 mg | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacain Sintetica 1,25
mg/ml | 5 x 1000 ml | | | N.O. | | soluzione per infusione: Bupivacaini Hydrochloridum Anhydricum 1.25 mg | Sintetica SA | B | FB | | G | |
| | | IPro | | | Bupivacaine Sterile Pack 0 | 5 ampoule(s) à 20 ml | | | N.O. | | Solution injectable: Bupivacaini Hydrochloridum Anhydricum 5 mg | Abbott AG | B | FB | | G | |
| | | IPro | | | Bupivacaine Sterile Pack 0 | 5 ampoule(s) à 20 ml | | | N.O. | | Solution injectable: 2 Principes actifs | Abbott AG | B | FB | | G | |
| | | IPro | | | Bupivacaine Sterile Pack 0 | 5 ampoule(s) à 20 ml | | | N.O. | | Solution injectable: Bupivacaini Hydrochloridum Anhydricum 7.5 mg | Abbott AG | B | FB | | G | |
|
| | | IPro | | | Lidocain CO2 Sintetica 20
mg/ml | Flacon perforable à 20 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Anhydricum 20 mg/ml | Sintetica SA | ● B | FB | | G | |
| | | IPro | | | Lidocain HCl Bichsel 5
mg/ml | 10 ampoule(s) | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Anhydricum 5 mg/ml | Laboratorium Dr. G.
Bichsel AG | B | FB | | G | |
| | | IPro | | | Lidocain HCl Bichsel 10
mg/ml | 10 ampoule(s) | | 13.05 | N.O. | | Solution injectable: Lidocaini Hydrochloridum Anhydricum 10 mg/ml | Laboratorium Dr. G.
Bichsel AG | B | FB | | G | |
| | | IPro | | | Lidocain HCl Bichsel 10
mg/ml | 10 ampoule(s) | | 16.30 | N.O. | | Solution injectable: Lidocaini Hydrochloridum Anhydricum 10 mg/ml | Laboratorium Dr. G.
Bichsel AG | B | FB | | G | |
| | | IPro | | | Lidocain HCl Bichsel 20
mg/ml | 10 ampoule(s) | | 16.30 | N.O. | | Solution injectable: Lidocaini Hydrochloridum Anhydricum 20 mg/ml | Laboratorium Dr. G.
Bichsel AG | ● B | FB | | G | |
| | | IPro | | | Lidocain Streuli Ampullen 10
mg/ml | 10 1 ampoule(s) à 2 ml | | 10.00 | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 10 mg/ml | Streuli Pharma AG | B | FB | | G | |
| | | IPro | | | Lidocain Streuli Ampullen 10
mg/ml | 10 1 ampoule(s) à 5 ml | | 10.95 | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 10 mg/ml | Streuli Pharma AG | B | FB | | G | |
| | | IPro | | | Lidocain Streuli
Durchstechflaschen 10
mg/ml | Flacon perforable à 50 ml | 3.05 | 7.60 | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 10 mg/ml | Streuli Pharma AG | B | FB | | G | |
| | | IPro | | | Lidocain Streuli Ampullen 10
mg/ml | 50 1 ampoule(s) à 2 ml | | 28.05 | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 10 mg/ml | Streuli Pharma AG | B | FB | | G | |
| | | IPro | | | Lidocain Streuli Ampullen 10
mg/ml | 10 1 ampoule(s) à 10 ml | | 12.95 | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 10 mg/ml | Streuli Pharma AG | ● B | FB | | G | |
| | | IPro | | | Lidocain Streuli Ampullen 10
mg/ml | 50 1 ampoule(s) à 5 ml | | 30.90 | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 10 mg/ml | Streuli Pharma AG | ● B | FB | | G | |
| | | IPro | | | Lidocain Streuli Ampullen 10
mg/ml | 50 1 ampoule(s) à 10 ml | | 29.25 | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 10 mg/ml | Streuli Pharma AG | ● B | FB | | G | |
| | | IPro | | | Lidocain Streuli
Durchstechflaschen 10
mg/ml | 10 1 Flacon perforable à 50 ml | | 45.75 | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 10 mg/ml | Streuli Pharma AG | B | FB | | G | |
| | | IPro | | | Lidocain Streuli Ampullen 20
mg/ml | 10 1 ampoule(s) à 2 ml | | 10.35 | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 20 mg/ml | Streuli Pharma AG | B | FB | | G | |
| | | IPro | | | Lidocain Streuli Ampullen 20
mg/ml | 10 1 ampoule(s) à 5 ml | | 12.20 | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 20 mg/ml | Streuli Pharma AG | B | FB | | G | |
| | | IPro | | | Lidocain Streuli
Durchstechflaschen 20
mg/ml | Flacon perforable à 50 ml | 3.40 | 8.00 | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 20 mg/ml | Streuli Pharma AG | ● B | FB | | G | |
| | | IPro | | | Lidocain Streuli Ampullen 20
mg/ml | 50 1 ampoule(s) à 2 ml | | 29.00 | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 20 mg/ml | Streuli Pharma AG | ● B | FB | | G | |
| | | IPro | | | Lidocain Streuli Ampullen 20
mg/ml | 50 1 ampoule(s) à 5 ml | | 35.00 | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 20 mg/ml | Streuli Pharma AG | B | FB | | G | |
| | | IPro | | | Lidocain Streuli
Durchstechflaschen 20
mg/ml | 10 1 Flacon perforable à 50 ml | | 51.65 | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 20 mg/ml | Streuli Pharma AG | ● B | FB | | G | |
| | | IPro | | | Rapidocain 5 mg/ml | Flacon perforable à 20 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Anhydricum 5 mg/ml | Sintetica SA | B | FB | | G | |
| | | IPro | | | Rapidocain 10 mg/ml | Flacon perforable à 20 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Anhydricum 10 mg/ml | Sintetica SA | B | FB | | G | |
| | | IPro | | | Rapidocain 10 mg/ml | 10 1 ampoule(s) à 5 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Anhydricum 10 mg/ml | Sintetica SA | B | FB | | G | |
| | | IPro | | | Rapidocain 10 mg/ml con
agenti conservanti | Flacon perforable à 50 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Anhydricum 10 mg/ml | Sintetica SA | B | FB | | G | |
| | | IPro | | | Rapidocain 10 mg/ml | 10 1 ampoule(s) à 10 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Anhydricum 10 mg/ml | Sintetica SA | B | FB | | G | |
| | | IPro | | | Rapidocain 20 mg/ml | 10 1 ampoule(s) à 2 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Anhydricum 20 mg/ml | Sintetica SA | B | FB | | G | |
| | | IPro | | | Rapidocain 20 mg/ml | Flacon perforable à 20 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Anhydricum 20 mg/ml | Sintetica SA | B | FB | | G | |
| | | IPro | | | Rapidocain 20 mg/ml | 10 1 ampoule(s) à 5 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Anhydricum 20 mg/ml | Sintetica SA | B | FB | | G | |
| | | IPro | | | Rapidocain 20 mg/ml con
agenti conservanti | Flacon perforable à 50 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Anhydricum 20 mg/ml | Sintetica SA | B | FB | | G | |
| | | IPro | | | Xylesin mit Konservans 5
mg/ml | 50 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 5 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | | G | |
| | | IPro | | | Xylesin mit Konservans 5
mg/ml | 100 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 5 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | | G | |
| | | IPro | | | Xylesin mit Konservans 5
mg/ml | 10 x 50 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 5 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | | G | |
| | | IPro | | | Xylesin 10 mg/ml | 10 x 2 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 10 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | | G | |
| | | IPro | | | Xylesin mit Konservans 10
mg/ml | 50 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 10 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | | G | |
| | | IPro | | | Xylesin 10 mg/ml | 10 x 5 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 10 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | | G | |
| | | IPro | | | Xylesin mit Konservans 10
mg/ml | 100 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 10 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | | G | |
| | | IPro | | | Xylesin 10 mg/ml | 10 x 10 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 10 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | | G | |
| | | IPro | | | Xylesin 10 mg/ml | 100 x 2 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 10 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | | G | |
| | | IPro | | | Xylesin mit Konservans 10
mg/ml | 10 x 50 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 10 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | | G | |
| | | IPro | | | Xylesin 10 mg/ml | 100 x 5 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 10 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | | G | |
| | | IPro | | | Xylesin 10 mg/ml | 100 x 10 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 10 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | | G | |
| | | IPro | | | Xylesin 20 mg/ml | 10 x 1 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 20 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | | G | |
| | | IPro | | | Xylesin 20 mg/ml | 10 x 2 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 20 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | | G | |
| | | IPro | | | Xylesin mit Konservans 20
mg/ml | 50 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 20 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | | G | |
| | | IPro | | | Xylesin 20 mg/ml | 10 x 5 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 20 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | | G | |
| | | IPro | | | Xylesin 20 mg/ml | 100 x 1 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 20 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | | G | |
| | | IPro | | | Xylesin 20 mg/ml | 100 x 2 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 20 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | | G | |
| | | IPro | | | Xylesin mit Konservans 20
mg/ml | 10 x 50 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 20 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | | G | |
| | | IPro | | | Xylesin 20 mg/ml | 100 x 5 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 20 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | | G | |
| | | IPro | | | Lidocain Leman | 30 ml | | | N.O. | | gel: Lidocaini Hydrochloridum Anhydricum 20 mg | Leman SKL SA | B | FB | | G | |
| | | IPro | | | Xylocain 20 mg/g | 30 g | | | N.O. | | gel: Lidocaini Hydrochloridum Anhydricum 20 mg | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | IPro | | | Xylocain | 50 ml | | | N.O. | | Spray: Lidocainum 10 mg | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | IPro | | | Lidocaine Aguettant 10
mg/ml | 10 x 10 ml | | | N.O. | | solution injectable en seringue préremplie: Lidocaini Hydrochloridum Anhydricum 10 mg/ml | Aguettant Suisse SA | B | FB | | G | |
| | | IPro | | | Lidocaine Aguettant 20
mg/ml | 10 x 10 ml | | | N.O. | | solution injectable en seringue préremplie: Lidocaini Hydrochloridum Anhydricum 20 mg/ml | Aguettant Suisse SA | B | FB | | G | |
| | | IPro | | | Rapidocain 10 mg/ml con
agenti conservanti | Flacon perforable à 20 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Anhydricum 10 mg/ml | Sintetica SA | B | FB | | G | |
| | | IPro | | | Rapidocain 20 mg/ml con
agenti conservanti | Flacon perforable à 20 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Anhydricum 20 mg/ml | Sintetica SA | B | FB | | G | |
| | | IPro | | | Rapidocain 20 mg/ml | 10 1 ampoule(s) à 10 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Anhydricum 20 mg/ml | Sintetica SA | B | FB | | G | |
| | | IPro | | | Xylesin mit Konservans 20
mg/ml | 100 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 20 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | | G | |
| | | IPro | | | Xylesin 20 mg/ml | 10 x 10 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 20 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | | G | |
| | | IPro | | | Xylesin 20 mg/ml | 100 x 10 ml | | | N.O. | | Solution injectable: Lidocaini Hydrochloridum Monohydricum 20 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | | G | |
| | | IPro | | | Lidocaine Aguettant 10
mg/ml | 10 x 5 ml | | | N.O. | | solution injectable en seringue préremplie: Lidocaini Hydrochloridum Anhydricum 10 mg/ml | Aguettant Suisse SA | B | FB | | G | |
| | | IPro | | | Lidocaine Aguettant 20
mg/ml | 10 x 5 ml | | | N.O. | | solution injectable en seringue préremplie: Lidocaini Hydrochloridum Anhydricum 20 mg/ml | Aguettant Suisse SA | B | FB | | G | |
|
| L | | IPro | IPat | | Anesderm | 5 g | 3.12 | 12.65 | 10% | | Crème: 2 Principes actifs | Pierre Fabre Pharma SA | B / LS | FB | | G | |
| L | | IPro | IPat | | Anesderm | 5 x 5 g | 15.60 | 33.40 | 10% | | Crème: 2 Principes actifs | Pierre Fabre Pharma SA | B / LS | FB | | G | |
| L | | IPro | IPat | | Prilid Leman | 5 g | 3.00 | 12.50 | 10% | | Crème: 2 Principes actifs | Leman SKL SA | B / LS | FB | | G | |
| L | | IPro | IPat | | Prilid Leman | 5 x 5 g | 9.45 | 26.70 | 10% | | Crème: 2 Principes actifs | Leman SKL SA | ● B / LS | FB | | G | |
| L | | IPro | IPat | | Prilid Leman | 30 g | 16.80 | 34.70 | 10% | | Crème: 2 Principes actifs | Leman SKL SA | B / LS | FB | | G | |
| | | IPro | IPat | | Anesderm | 30 g | | | N.O. | | Crème: 2 Principes actifs | Pierre Fabre Pharma SA | B | FB | | G | |
| | | IPro | IPat | | Emla | 5 x 5 g | | 55.60 | N.O. | | Crème: 2 Principes actifs | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | IPro | IPat | | Emla | 30 g | | 53.70 | N.O. | | Crème: 2 Principes actifs | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | IPro | IPat | | Prilid Leman | 5 g | | | N.O. | | Crème: 2 Principes actifs | Leman SKL SA | B | FB | | G | |
| | | IPro | IPat | | Prilid Leman | 5 g | | | N.O. | | Crème: 2 Principes actifs | Leman SKL SA | B | FB | | G | |
| | | IPro | IPat | | Prilid Leman | 5 x 5 g | | | N.O. | | Crème: 2 Principes actifs | Leman SKL SA | B | FB | | G | |
| | | IPro | IPat | | Prilid Leman patch | 2 | | | N.O. | | emplâtre médicamenteux: 2 Principes actifs | Leman SKL SA | B | FB | | G | |
| | | IPro | IPat | | Prilid Leman patch | 20 | | | N.O. | | emplâtre médicamenteux: 2 Principes actifs | Leman SKL SA | B | FB | | G | |
| | | IPro | IPat | | Emla | 2 | | | N.O. | | wirkstoffhaltiges Pflaster: 2 Principes actifs | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | IPro | IPat | | Emla | 20 | | | N.O. | | wirkstoffhaltiges Pflaster: 2 Principes actifs | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
|
| | | IPro | | | Carbostesin-Adrenalin
0,25 % | 5 1 Flacon perforable à 20 ml | | 51.25 | N.O. | | Solution injectable: 2 Principes actifs | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
| | | IPro | | | Carbostesin-Adrenalin 0,5 % | 5 1 Flacon perforable à 20 ml | | 53.95 | N.O. | | Solution injectable: 2 Principes actifs | Ipsen Pharma Schweiz
GmbH | B | FB | | G | |
|
| | | IPro | | | Rudocain | 100 Zylinderampulle(n) | | | N.O. | | Solution injectable: 2 Principes actifs | Streuli Pharma AG | ● B | FB | | G | |
| | | IPro | | | Rudocain forte | 100 Zylinderampulle(n) | | | N.O. | | Solution injectable: 2 Principes actifs | Streuli Pharma AG | ● B | FB | | G | |
| | | IPro | | | Septanest adrénalinée
1/200.000 | 50 x 1.7 ml | | | N.O. | | Solution injectable: 2 Principes actifs | Materia Medica
Maibach AG | B | FB | | G | |
| | | IPro | | | Septanest adrénalinée
1/100.000 | 50 x 1.7 ml | | | N.O. | | Solution injectable: 2 Principes actifs | Materia Medica
Maibach AG | B | FB | | G | |
| | | IPro | | | Ultracain D-S | 100 1 Zylinderampulle(n) à 1.7 ml | | | N.O. | | Solution injectable: 2 Principes actifs | Materia Medica
Maibach AG | B | FB | | G | |
| | | IPro | | | Ultracain D-S forte | 100 1 Zylinderampulle(n) à 1.7 ml | | | N.O. | | Solution injectable: 2 Principes actifs | Materia Medica
Maibach AG | B | FB | | G | |
| | | IPro | | | Ubistesin mite | 50 x 1.7 ml | | | N.O. | | Solution injectable: 2 Principes actifs | Medius AG | B | FB | | G | |
| | | IPro | | | Ubistesin | 50 1 Zylinderampulle(n) à 1.7 ml | | | N.O. | | Solution injectable: 2 Principes actifs | Medius AG | B | FB | | G | |
| | | IPro | | | Ubistesin forte | 50 1 Zylinderampulle(n) à 1.7 ml | | | N.O. | | Solution injectable: 2 Principes actifs | Medius AG | B | FB | | G | |
|
| | | IPro | | | Aethylchlorid Sintetica | Spray(s) à 100 g | | 6.25 | N.O. | | spray cutaneo: Chloroethanum 100 g | Sintetica SA | B | FB | | G | |
|
| L | | IPro | IPat | | Qutenza | pansement(s) | 238.37 | 275.65 | 10% | | kutanes Pflaster: Capsaicinum 179 mg | Grünenthal Pharma AG | A / LS | FB | | G | |
| L | | IPro | IPat | | Qutenza | 2 pansement(s) | 419.53 | 472.70 | 10% | | kutanes Pflaster: Capsaicinum 179 mg | Grünenthal Pharma AG | A / LS | FB | | G | |
